AstraZeneca is a biopharmaceutical firm that researches, creates, produces, and markets prescription drugs across multiple therapeutic areas including oncology, cardiovascular disease, kidney and metabolic disorders, respiratory and immune conditions, vaccines, and rare diseases. The company maintains a diverse portfolio of medications and distributes its products to healthcare providers through various channels across the United Kingdom, United States, Europe, Asia, Africa, and Australia. AstraZeneca also pursues collaborative agreements with technology and research partners to advance drug discovery and development initiatives.
1Y: 186.65 (+14.4%) · range 155.62–208.62
entry readiness 17 · NOT READY · exit proximity 15
Value area 155.13–173.19 · 7% of 120d volume overhead · clean runway
| Source | Score | Last seen |
|---|---|---|
| trader-sentiment | 0.148 | Oct 30, 2026 |
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +3.68% | +4.33% | 5/20d |
| 40d | +3.68% | +4.33% | 5/40d |